Radiological characteristics based on isocitrate dehydrogenase mutations and 1p/19q codeletion in grade II and III gliomas

Glioma Groups Based on 1p/19q,<i>IDH</i>, and<i>TERT</i>Promoter Mutations in Tumors

Jeanette E. Eckel‐Passow, Daniel H. Lachance, Annette M Molinaro et al. · New England Journal of Medicine · 2015 · 1.9K citations · Full text

Mutational landscape and clonal architecture in grade II and III gliomas

Hiromichi Suzuki, Kosuke Aoki, Kenichi Chiba et al. · Nature Genetics · 2015 · 832 citations

Neuro-oncology, Developmental Biology, Somatic Variant +13

Evidence for Sequenced Molecular Evolution of <i>IDH1</i> Mutant Glioblastoma From a Distinct Cell of Origin

Albert Lai, Samir Kharbanda, Whitney B. Pope et al. · Journal of Clinical Oncology · 2011 · 438 citations · Full text

ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an “integrated” diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma

Felix Sahm, Daniel Schrimpf, Benedikt Wiestler et al. · Acta Neuropathologica · 2014 · 437 citations · Full text

Neuro-oncology, Idh1-r132h Immunohistochemistry, Tumoral Pathology +13

Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups

Michael Weller, Ruthild G. Weber, Edith Willscher et al. · Acta Neuropathologica · 2015 · 307 citations · Full text

Pathology, High-grade Gliomas, Brain Lesion +18